CAR T 细胞疗法

打印

科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业，通过齐心协力确保高品质治疗与成功康复。

有相关专长的科室

研究此手术的领域

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

姓氏首字母: B

  1. N. Nora Bennani, M.D.

    N. Nora Bennani, M.D.

    1. Internist
    2. Oncologist
    3. Hematologist
    1. Rochester, MN
    擅长领域：

    CAR-T cell therapy, Cutaneous t-cell lymphoma, Lymphoma, Sezary syndrome, B-cell lymphoma, Follicular lymphoma, Periphe...ral T-cell lymphoma, T-cell lymphoma

  2. Matthew S. Block, M.D., Ph.D.

    Matthew S. Block, M.D., Ph.D.

    1. Oncologist
    1. Rochester, MN
    擅长领域：

    CAR-T cell therapy, Biological therapy for cancer, Gynecologic cancer, Melanoma

研究

妙佑医疗国际的医生和研究人员正在研究改善血癌治疗方案的方法，包括 CAR-T 细胞疗法和其他癌症治疗创新。

血癌研究系与妙佑医疗国际综合癌症中心合作开展。妙佑医疗国际综合癌症中心接受美国国家癌症研究所资金，是指定的综合癌症中心。这是对该机构在癌症预防、诊断和治疗方面的卓越科学成就和多学科资源的认可。

著述

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际的医生在 CAR-T 细胞疗法领域的著述目录。

Research Profiles

来自妙佑医疗国际员工

在 Mayo Clinic 治疗

关于在 Mayo Clinic 治疗
Nov. 14, 2025
打印
  1. Brudno JN, et al. CAR T cells and T-cell therapies for cancer. JAMA. 2024; doi:10.1001/jama.2024.19462.
  2. CAR T cells: Engineering patients' immune cells to treat their cancers. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/research/car-t-cells. Accessed April 16, 2025.
  3. Kymriah (prescribing information). Novartis; 2024. https://us.kymriah.com. Accessed April 24, 2025.
  4. Yescarta (prescribing information). Kite Pharma; 2024. https://www.yescartahcp.com. Accessed April 24, 2025.
  5. Tecartus (prescribing information). Kite Pharma; 2024. https://www.tecartushcp.com. Accessed April 24, 2025.
  6. Breyanzi (prescribing information). Bristol Myers Squibb; 2024. https://www.breyanzihcp.com. Accessed April 24, 2025.
  7. Abecma (prescribing information). Bristol Myers Squibb; 2024. https://www.abecma.com/. Accessed April 24, 2025.
  8. Carvykti (prescribing information). Janssen Biotech; 2024. https://www.carvykti.com. Accessed April 24, 2025.
  9. Aucatzyl (prescribing information). Autolus; 2024. https://www.autolus.com. Accessed April 24, 2025.
  10. Roddie C, et al. Obecabtagene autoleucel in adults with B-cell acute lymphoblastic leukemia. New England Journal of Medicine. 2024; doi:10.1056/NEJMoa2406526.
  11. Immunotherapy side effects: CAR T-cell therapy. National Comprehensive Cancer Network. http://www.NCCN.org/patientguidelines. Accessed April 16, 2025.
  12. Hines MR, et al. Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome. Transplantation and Cellular Therapy. 2023; doi:10.1016/j.jtct.2023.03.006.
  13. Amini L, et al. Preparing for CAR T cell therapy: Patient selection, bridging therapies and lymphodepletion. Nature Reviews: Clinical Oncology. 2022; doi:10.1038/ s41571-022-00607-3.
  14. Steinbach M, et al. Nursing care throughout the chimeric antigen receptor T-cell therapy process for multiple myeloma. Seminars in Oncology Nursing. 2023; doi:10.1016/j.soncn.2023.151505.
  15. Acute lymphoblastic leukemia. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1410. Accessed April 22, 2025.
  16. B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480. Accessed April 22, 2025.
  17. Chronic lymphocytic leukemia. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1478. Accessed April 22, 2025.
  18. Multiple myeloma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1445. Accessed April 22, 2025.
  19. Shoushtari AN, et al. Principles of cancer immunotherapy. https://www.uptodate.com/contents/search. Accessed April 21, 2025.
  20. T-cell transfer therapy. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy. Accessed April 24, 2025.
  21. Health Education & Content Services. Chimeric antigen receptor T-cell (CAR-T) therapy. Mayo Clinic; 2019.
  22. Bashir Q, et al., eds. Process and general management of patients undergoing chimeric antigen receptor therapies. In: Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Elsevier; 2024. https://www.clinicalkey.com. Accessed May 1, 2025.
  23. Neelapu SS, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. New England Journal of Medicine. 2017; doi:10.1056/NEJMoa1707447.

相关

Mayo Clinic 新闻

产品与服务

CAR T 细胞疗法